Astronova, Inc.
A maker of specialized printers and data-visualization gear, AstroNova builds the QuickLabel and TrojanLabel machines that print product labels and packaging, plus the rugged ToughWriter printers used in airplane flight decks. Founded in 1969 in Rhode Island as Astro-Med, it got its name from its two original markets—aerospace and medical—and its early recorders were used by NASA. It dropped the "Med" and became AstroNova in 2016 after leaving the medical business.
This Amendment No. 3 to Schedule 13D (this 'Amendment No. 3') amends and supplements the Schedule 13D filed on August 29, 2025 (as amended and supplemented through the date of this Amendment No. 1) by the Reporting Persons relating to the common stock of the Issuer. The shares of Common Stock covered by this statement were originally acquired by the Reporting Persons in the ordinary course of business solely for investment purposes and not for the purposes of participating in or influencing the management of the Issuer. This Amendment No. 3 is being filed for the purpose of reporting a decrease in the percentage of the class of securities beneficially owned by the Reporting Persons and constitutes an 'exit filing' with respect to Schedule 13D for the Reporting Persons. The related updates and amendments to the Schedule 13D are listed below. As published in a press release on June 17, 2026, the Issuer is to be acquired by another issuer based. This fact, among others, has prompted the Reporting Persons to decrease their position in the Issuer below the reportable 5% threshold. The Reporting Persons are supportive of the Issuer's proposed acquisition by Arcline, which they believe maximizes shareholder value. As a result, the Reporting Persons are supportive of the Issuer's current strategy at this time and have no current plans to engage in any further actions to influence the company's strategy or Board composition. Except as set forth above, or as would occur upon completion of any of the matters discussed herein, the Reporting Persons have no present plans or intentions which would result in or relate to any of the transactions described in subparagraphs (a) through (j) of Item 4 of Schedule 13D. Although the foregoing reflects activities presently contemplated by the Reporting Persons with respect to the Issuer, the foregoing is subject to change at any time.
This Amendment No. 3 to Schedule 13D (this 'Amendment No. 3') amends and supplements the Schedule 13D filed on August 29, 2025 (as amended and supplemented through the date of this Amendment No. 1) by the Reporting Persons relating to the common stock of the Issuer. The shares of Common Stock covered by this statement were originally acquired by the Reporting Persons in the ordinary course of business solely for investment purposes and not for the purposes of participating in or influencing the management of the Issuer. This Amendment No. 3 is being filed for the purpose of reporting a decrease in the percentage of the class of securities beneficially owned by the Reporting Persons and constitutes an 'exit filing' with respect to Schedule 13D for the Reporting Persons. The related updates and amendments to the Schedule 13D are listed below. As published in a press release on June 17, 2026, the Issuer is to be acquired by another issuer based. This fact, among others, has prompted the Reporting Persons to decrease their position in the Issuer below the reportable 5% threshold. The Reporting Persons are supportive of the Issuer's proposed acquisition by Arcline, which they believe maximizes shareholder value. As a result, the Reporting Persons are supportive of the Issuer's current strategy at this time and have no current plans to engage in any further actions to influence the company's strategy or Board composition. Except as set forth above, or as would occur upon completion of any of the matters discussed herein, the Reporting Persons have no present plans or intentions which would result in or relate to any of the transactions described in subparagraphs (a) through (j) of Item 4 of Schedule 13D. Although the foregoing reflects activities presently contemplated by the Reporting Persons with respect to the Issuer, the foregoing is subject to change at any time.
| Holder | Schedule | % of class | Shares | Filed |
|---|---|---|---|---|
| ASKELADDEN CAPITAL MANAGEMENT LLC | 13D/AActivist | 0.4% | 32.4K | Jul 23, 2026 |
This Amendment No. 3 to Schedule 13D (this 'Amendment No. 3') amends and supplements the Schedule 13D filed on August 29, 2025 (as amended and supplemented through the date of this Amendment No. 1) by the Reporting Persons relating to the common stock of the Issuer. The shares of Common Stock covered by this statement were originally acquired by the Reporting Persons in the ordinary course of business solely for investment purposes and not for the purposes of participating in or influencing the management of the Issuer. This Amendment No. 3 is being filed for the purpose of reporting a decrease in the percentage of the class of securities beneficially owned by the Reporting Persons and constitutes an 'exit filing' with respect to Schedule 13D for the Reporting Persons. The related updates and amendments to the Schedule 13D are listed below. As published in a press release on June 17, 2026, the Issuer is to be acquired by another issuer based. This fact, among others, has prompted the Reporting Persons to decrease their position in the Issuer below the reportable 5% threshold. The Reporting Persons are supportive of the Issuer's proposed acquisition by Arcline, which they believe maximizes shareholder value. As a result, the Reporting Persons are supportive of the Issuer's current strategy at this time and have no current plans to engage in any further actions to influence the company's strategy or Board composition. Except as set forth above, or as would occur upon completion of any of the matters discussed herein, the Reporting Persons have no present plans or intentions which would result in or relate to any of the transactions described in subparagraphs (a) through (j) of Item 4 of Schedule 13D. Although the foregoing reflects activities presently contemplated by the Reporting Persons with respect to the Issuer, the foregoing is subject to change at any time. | ||||
| Samir Patel | 13D/AActivist | 0.4% | 32.4K | Jul 23, 2026 |
This Amendment No. 3 to Schedule 13D (this 'Amendment No. 3') amends and supplements the Schedule 13D filed on August 29, 2025 (as amended and supplemented through the date of this Amendment No. 1) by the Reporting Persons relating to the common stock of the Issuer. The shares of Common Stock covered by this statement were originally acquired by the Reporting Persons in the ordinary course of business solely for investment purposes and not for the purposes of participating in or influencing the management of the Issuer. This Amendment No. 3 is being filed for the purpose of reporting a decrease in the percentage of the class of securities beneficially owned by the Reporting Persons and constitutes an 'exit filing' with respect to Schedule 13D for the Reporting Persons. The related updates and amendments to the Schedule 13D are listed below. As published in a press release on June 17, 2026, the Issuer is to be acquired by another issuer based. This fact, among others, has prompted the Reporting Persons to decrease their position in the Issuer below the reportable 5% threshold. The Reporting Persons are supportive of the Issuer's proposed acquisition by Arcline, which they believe maximizes shareholder value. As a result, the Reporting Persons are supportive of the Issuer's current strategy at this time and have no current plans to engage in any further actions to influence the company's strategy or Board composition. Except as set forth above, or as would occur upon completion of any of the matters discussed herein, the Reporting Persons have no present plans or intentions which would result in or relate to any of the transactions described in subparagraphs (a) through (j) of Item 4 of Schedule 13D. Although the foregoing reflects activities presently contemplated by the Reporting Persons with respect to the Issuer, the foregoing is subject to change at any time. | ||||
| Glazer Capital, LLC | 13GPassive | 5.81% | 449.9K | Jun 25, 2026 |
| Paul J. Glazer | 13GPassive | 5.81% | 449.9K | Jun 25, 2026 |
| Dimensional Fund Advisors LP | 13G/APassive | 5.7% | 435.2K | Apr 9, 2026 |
| Punch & Associates Investment Management, Inc. | 13G/APassive | 4% | 301.4K | May 15, 2025 |
| ROYCE & ASSOCIATES LP | 13G/APassive | 4.55% | 342.4K | Apr 30, 2025 |